WNK2 and prostate carcinoma: Mitogen activating protein kinases (MAPKs) families, including c-Jun N terminal kinases (JNK), extracellular signal-regulated kinase (ERK), and MAPK p38 highly expressed in prostate cancer resulting in proliferation and invasion [12].